Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients-Reference-Cited by-同舟云学术

Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients

Published:2014-02 Issue:6 Volume:63 Page:528-536
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Matsumoto Yoshihiro,Mori Yasuo,Kageyama Shinji,Arihara Kazuo,Sugiyama Toshikazu,Ohmura Hiromichi,Yakushigawa Toru,Sugiyama Hatsumi,Shimada Yasushi,Nojima Youichi,Shio Nobuo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. VI. Causes of death in ESRD;Am J Kidney Dis,1999

2. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States;Marcelli;Kidney Int,1996

3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients;Yusuf;N Engl J Med,2000

4. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention (MOSES): principal results of a prospective randomized controlled study;Schrader;Stroke,2005

5. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol;Dahlof;Lancet,2002

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease;Frontiers in Pharmacology;2024-09-04

2. Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models;International Journal of Molecular Sciences;2024-08-22

3. Management of patients with heart failure and chronic kidney disease;Heart Failure Reviews;2024-07-29

4. Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study;Nephrology Dialysis Transplantation;2024-07-10

5. Effect of spironolactone on survival in patients undergoing maintenance hemodialysis;PLOS ONE;2024-03-29